FY23 Appropriations: Ready, Set, Go. Part 2. Announcement of Alliance FY 23 Budget Priorities webinar series with FDA leaders.
Top-Line:
Analysis and Commentary: Insight on FDA funding and release of the President’s FY 23 budget request on March 28.
FY23 Appropriations: Ready, Set, Go. Part 2.
FDA Receives $102 million increase in FY 22 Omnibus.
Alliance campaign encourages Members of Congress to request increased FDA funding.
Do not miss the Alliance’s budget priorities webinar series with FDA leaders.
Patrizia Cavazzoni, MD | CDER | April 4, 1 p.m. | Register
Judith McMeekin | ORA | April 6, 2 p.m. | Register
Susan Mayne, PhD | CFSAN | April 12, 11 a.m. | Register
Steven Solomon, DVM | CVM | April 22, 3 p.m. | Register
Jeff Shuren, MD | CDRH | April 29, 11 a.m. | Register
Peter Marks, MD | CBER | May 10, 1 p.m. | Register
This week’s Analysis and Commentary looks at the forthcoming FY 23 President’s Budget Release and how Alliance members should interpret the “headline numbers” from OMB.
FY 23 Budget Request: Ready, Set, Go. Part 2. The President delivered his State of the Union address on March 1, an event that traditionally kicks off the coming appropriations cycle. We expect the President’s Budget Request to be released on March 28, 2022.
FDA Receives $103 Million Increase in FY 22 Omnibus. The increase of $102.4 million dollars would be split $29 million to medical product safety, $29.5 million for food safety, $41.3 million for cross-cutting initiatives. The projects that would be funded are described in last week’s Analysis and Commentary. The text and explanatory statement are linked here.
In a release to the media, the Alliance said: "The Alliance for a Stronger FDA thanks Congressional appropriators for their continued support of the FDA, as reflected in the just-released conference agreement on FY 22 appropriations funding. The $102 million increase (3.2%) is much needed and will strengthen programs throughout the agency.”
Alliance Campaign Encourages Members of Congress to Request Increased FDA Funding. During March and April of each year, Members of Congress ask their constituents and interested parties to recommend program funding for the coming fiscal year. In turn, Members formulate a list of their priorities, which they share with subcommittee leadership. Requests can be highly localized (monies to rebuild a bridge) or broadly programmatic (increases for FDA, for example).
Every year, the Alliance reaches out to Members of Congress to encourage them to tell appropriators “Increased FDA funding is one of my priorities.” We would like to broaden our efforts so Congressional offices receive 2 or 3 requests on behalf of FDA, rather than just ours.
Here is a link to an earlier Analysis and Commentary that contains more details. If you are interested in participating, please contact Roger Szemraj of the Alliance staff.
Don’t Miss Out on the Alliance’s Budget Priorities Webinar Series with FDA Leaders. Starting April 4, the Alliance will be holding an FY 23 Budget Priorities Webinar Series, with presentations from the five Center Directors and the Associate Commissioner for Regulatory Affairs.
Patrizia Cavazzoni, MD | CDER | April 4, 1 p.m. | Register
Judith McMeekin | ORA | April 6, 2 p.m. | Register
Susan Mayne, PhD | CFSAN | April 12, 11 a.m. | Register
Steven Solomon, DVM | CVM | April 22, 3 p.m. | Register
Jeff Shuren, MD | CDRH | April 29, 11 a.m. | Register
Peter Marks, MD | CBER | May 10, 1 p.m. | Register
These online events are for Alliance members and media, although we welcome guests. If you are not an Alliance member and would like to participate, please contact Alliance Executive Director, Steven Grossman.